3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
17
Fallopian Tube Neoplasms
15
Breast Neoplasms
7
Sarcoma
5
Neoplasm Metastasis
4
Carcinoma, Ovarian Epithelial
4
Neoplasms
3
Triple Negative Breast Neoplasms
2
Sarcoma, Ewing
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Multi-centric Castleman's Disease
2
Hodgkin Disease
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Vaccinia
1
Uterine Cervical Neoplasms
1
Sarcoma, Synovial
1
Sarcoma, Kaposi
1
Rhabdomyosarcoma
1
Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma
1
Recurrent Epithelial Ovarian, Fallopian or Peritoneal Carcinoma
1
Recurrence
1
Peritoneal Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Cancer Recurrent
1
Osteosarcoma
1
Macular dystrophy, corneal type 1
1
Lymphoproliferative Disorders
1
Lymphoma, Non-Hodgkin
1
Lymphadenopathy
1
Interventions
fludarabine
10
ruxolitinib
9
fludarabine phosphate
9
Whole-Body Irradiation
9
Specimen Handling
9
Cyclophosphamide
8
Azacitidine
8
Mycophenolic Acid
7
Cytarabine
7
Busulfan
7
Biopsy
7
Tacrolimus
6
venetoclax
5
Stem Cell Transplantation
5
Sirolimus
5
Peripheral Blood Stem Cell Transplantation
5
Injections
5
Granulocyte Colony-Stimulating Factor
5
Melphalan
4
Cyclosporine
4
CPX-351
4
luspatercept
3
ivosidenib
3
decitabine and cedazuridine drug combination
3
Thiotepa
3
Methotrexate
3
Liposomes
3
Idarubicin
3
Daunorubicin
3
Cyclosporins
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myeloproliferative Disorders
×
liposomal doxorubicin
×
90 days
×
Clear all
No trials found.